Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve 1. Audited financial results for the quarter and financial year ended 31.03.2025.\r\n2. Audited standalone and consolidated accounts of the Company together with reports of Directors and auditors there on.\r\n3. Recommendation of Dividend if any, for the financial year 2024.25.\r\n4.Appointment of Internal Auditors and Cost Auditors for the financial year 2025.26\r\n5. Appointment of Secretarial Auditors for five consecutive years , subject to the approval of shareholders.